Business of Medicine
Feature
From Scrubs to Social Media: How Some Med Students Become Influencers
Med students discussed why and how frequently they post on social media.
Feature
Patient Navigators for Serious Illnesses Can Now Bill Under New Medicare Codes
New Medicare codes will enable physicians to hire navigators to help patients manage serious illnesses such as cancer and heart failure.
Latest News
Do Neurology Patient Advocacy Groups Wield Too Much Power?
Just because a group has deep pockets does not mean that its priorities align with the disease burden.
Latest News
No Surprises Act: Private Equity Scores Big in Arbitrations
Private equity–owned organizations are forcefully challenging insurers about payments for certain kinds of out-of-network care.
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
Feature
Doctors Are Seeking Professional Coaches More Often. Here’s Why
More and more doctors are using professional coaching to manage life in medicine. The coaches, also physicians, say it might be a cure for burnout...
Latest News
FDA ‘Recalls’ Often Leave Targeted Medical Devices in Use
Recent FDA “recalls” of medical devices actually issue corrections to instructions rather than removal from use.
Feature
FTC Interim Report on Pharmacy Middlemen Is First Step of Many Needed in Addressing Drug Costs, Access
Madelaine Feldman, MD, has been a vocal PBM critic for years. She sees a recent FTC interim report as evidence of the need for congressional...
Commentary
What Would ‘Project 2025’ Mean for Health and Healthcare?
Conservative group–backed plan intends to alter the processes and/or funding of CDC, NIH, Medicaid, and other agencies.
Hitting a Nerve
The Digital Side Effects
The CrowdStrike outage is a reminder of how vulnerable our whole world is to disruption of the internet.
Feature
Immunotherapy May Be Overused in Dying Patients With Cancer
“There are patients who are getting immunotherapy who shouldn’t,” according to a surgical oncologist from Yale.